The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPPIX.L Regulatory News (PPIX)

  • There is currently no data for PPIX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

1st Quarter Results

4 May 2011 07:00

RNS Number : 8629F
ProPhotonix Limited
04 May 2011
 



 

 

4 May 2011

 

 

ProPhotonix Limited

 ("ProPhotonix" or "the Company")

 

FIRST QUARTER TRADING UPDATE

 

ProPhotonix Limited, (London Stock Exchange - AIM: PPIX and PPIR, OTC: STKR.PK), a designer and manufacturer of LED systems and laser modules as well as a distributor of premium vendors' laser diodes, announces its financial results for the first quarter ended March 31, 2011.

 

 

First-Quarter 2011 Financial Highlights:

·; Revenue increased by 25% to $4.3 million (Q1 2010: $3.5 million), up 24% adjusting for impact of currency fluctuation

·; Revenue up 5% sequentially versus the fourth quarter of 2010

·; Six consecutive quarters of sequential growth

·; LED revenue increased 79% to $2.3 million (Q1 2010: $1.3 million)

·; Gross profit increased 38% from $1.2 million to $1.6 million

·; Gross margin 38.0% (Q1 2010: 34.2%) (Q4 2010: 39.0%)

·; EBITDA profit of $29,000 vs. $247,000 loss in 2010, adjusted for an abandoned facility charge, and a loss of $48,000 in Q4 2010, adjusted for AIM expenses of $50,000

·; Order bookings $4.9 million, ending backlog $6.4 million

·; Percentage revenue by market sectors: industrial 80%, medical 14% and homeland security & defense 6%;

·; Percentage revenue by geography: 53% Europe, 38% North America and 9% Rest of World

 

 

Mark W. Blodgett, Chairman & CEO, said: "I am pleased to announce these results for the first quarter ended March 31, 2011. The Company grew 25% year over year and 5% sequentially, marking the sixth straight quarter of sequential revenue growth. Geographically, ProPhotonix achieved improved sales in the North American market, where we had 53% year over year growth, and 45% growth sequentially. We also achieved continued growth in the European market led by strong sales to the German solar equipment industry. The industrial and medical market sales were up year over year at 35% and 9% respectively, however, homeland security & defense sales were down 24% mainly due to lower laser diode sales to one defense customer."

 

"Order bookings at $4.9 million were strong, particularly at the end of the first quarter, which bodes well for continued growth, particularly in the Company's LED business. Profitability improved measurably as sales, general and administrative expenses were flat year over year and the Company achieved EBITDA breakeven for the period compared to a $0.2 million loss the prior year first quarter."

 

 

 

Enquiries:

 

ProPhotonix Limited

Mark W. Blodgett, CEO

 

Tel: +44 (0)12 7971 7170

ir@prophotonix.com

Libertas Capital Corporate Finance Limited

Andrew McLennan / Thilo Hoffmann

 

Tel: +44 (0)20 7569 9650

Cubitt Consulting

Chris Lane / Alice Coubrough

Tel: +44 (0) 20 7367 5100

 

 

RD:IR

Isabel Richardson / Thomas Churchill

Tel: +44 (0) 20 7492 0500

 

 

 

About ProPhotonix

ProPhotonix Limited, headquartered in Salem, New Hampshire, is an independent designer and manufacturer of diode-based laser modules and LED systems for industry leading OEMs and medical equipment companies. In addition, the Company distributes premium diodes for Opnext, Sanyo & Sony. The Company serves a wide range of markets including the machine vision, industrial inspection, defense, sensors, and medical markets. ProPhotonix has offices and subsidiaries in the U.S., Ireland, and Europe. For more information about ProPhotonix and its innovative products, visit the Company's web site at www.prophotonix.com.

 

 

 

 

 

First Quarter 2011 Financial Results

 

Total revenue for the first quarter of 2011 of $4.3 million increased 25 percent (up 24%, adjusting for currency) from the first quarter of 2010. The growth in revenue was comprised of an increase in the LED segment of $1.0 million (+79%) over last year and a decrease in the laser segment of approximately $0.1 million (-6%). The growth in revenues is mainly attributable to increased activities in the U.S.A. and Europe, where the Company saw year-on-year increases of approximately 76% and 17% respectively. Bookings for the first quarter of 2011 were $4.9 million and backlog was $6.4 million at March 31, 2011.

Gross profit was $1.6 million for the first quarter of 2011, an increase of 38% compared to $1.2 million in the first quarter of 2010. First quarter 2011 gross profit margin was 38.0% compared with 34.2% in the comparable quarter in 2010 due to higher volumes, a more favorable product mix, and productivity improvement initiatives.  

Operating expenses, excluding amortization charges, totaled $1.8 million for the first quarter of 2011, an increase of 5% versus $1.7 million in the first quarter of 2010, net of the charges related to an abandoned facility. General and Administrative expenses decreased approximately $0.1 million, mainly due to a decrease in facility depreciation costs related to the Salem facility, and decreased stock compensation charges. Selling expenses increased $0.1 million, or 26%, in line with the 25% revenue growth; while R&D expenses increased 56%, or by approximately $0.1 million. The net loss from continuing operations was $0.2 million as compared to a net operating loss of $0.6 million for the first quarter 2010, net of the charges related to the abandoned facility.

 

EBITDA was $29,000 for the quarter as compared to a $247,000 loss for the first quarter of 2010, net of a charge for an unused facility of $0.1 million. Net loss of $0.3 million includes a gain on foreign currency translation charges of $0.1 million. In comparison, the 2010 net loss was $1.3 million, which includes a loss on foreign currency translation charges of approximately $0.3 million.

 

 

Outlook

 

The Company continues to exhibit significant improvement in its overall financial performance versus last year as evidenced by a 79% increase in the sales of the Company's LED products. LED products, particularly those sold into medical and solar equipment industries, exhibit robust gross margins, which when combined with higher revenue volumes and improved capacity utilization, led to an overall improvement in gross margin to 38% from 34% the prior year. Sales in the laser division declined 6% year over year primarily due to higher sales of laser diodes in the first quarter of 2010, which benefited from a last time buy of several lines of discontinued diodes by an Asian diode manufacturer. The significant improvement in gross profit represents a significant accomplishment for the Company, which when combined with lower corporate overhead and ongoing cost management led to a significant improvement in overall financial operating performance. Based on strong first quarter order bookings and six consecutive quarters of sequential revenue growth and improved profitability, the Company is well positioned for 2011.

 

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements other than statements of historical fact, including without limitation, those with respect to ProPhotonix's goals, plans and strategies set forth herein are forward-looking statements. The following important factors and uncertainties, among others, could cause actual results to differ materially from those described in these forward-looking statements: uncertainty that cash balances may not be sufficient to allow ProPhotonix to meet all of its business goals; uncertainty that ProPhotonix's new products will gain market acceptance; the risk that delays and unanticipated expenses in developing new products could delay the commercial release of those products and affect revenue estimates; the risk that one of our competitors could develop and bring to market a technology that is superior to those products that we are currently developing; and ProPhotonix's ability to capitalize on its significant research and development efforts by successfully marketing those products that the Company develops. Forward-looking statements represent management's current expectations and are inherently uncertain. All Company, brand, and product names are trademarks or registered trademarks of their respective holders. ProPhotonix undertakes no duty to update any of these forward-looking statements.

 

 

 

Use of Non-GAAP Financial Measures

 

The Company provides non-GAAP financial measures, such as EBITDA, to complement its consolidated financial statements presented in accordance with GAAP. Non-GAAP financial measures do not have any standardized definition and, therefore, are unlikely to be comparable to similar measures presented by other reporting companies. These non-GAAP financial measures are intended to supplement the user's overall understanding of the Company's current financial and operating performance and its prospects for the future. Specifically, the Company believes the non-GAAP results provide useful information to both management and investors by identifying certain expenses, gains and losses that, when excluded from the GAAP results, may provide additional understanding of the Company's core operating results or business performance, which management uses to evaluate financial performance for purposes of planning for future periods. However, these non-GAAP financial measures are not intended to supersede or replace the Company's GAAP results.

 

The Company uses EBITDA (earnings before interest, taxes, depreciation, amortization, stock-based compensation and impairment charges) as a non-GAAP financial measure in this press release. A reconciliation of EBITDA to net income / (loss) for the first quarter ended 2011 is as follows:

 

 

Three Months Ended

(in thousands)

March 31,

2011

2010

Net Loss

(263)

(1,319)

Loss from discontinued operations

49

59

Plus:

Interest and other expense (net)

21

522

Depreciation

78

122

Intangible asset amortization

81

99

Stock based compensation

63

120

Tax benefit

-

(64)

Amortization of Debt Discount & Financing Costs

-

99

EBITDA Profit / (Loss)

29

(362)

Charges related to abandoned lease

-

115

Adjusted EBITDA Profit / (Loss)

29

(247)

 

Consolidated Statements of Operations

($ In thousands except share and per share data)

(unaudited)

 

Three Months Ended

March 31,

2011

2010

Net Sales

$4,338

$3,482

Cost of Sales

2,690

2,290

Gross Profit

1,648

1,192

Research & Development Expenses

239

153

Selling, General & Administrative Expenses

1,521

1,643

Amortization of Intangible Assets

81

99

Operating Loss

(193)

(703)

Other Income / (Expense), net

75

(328)

Amortization of Debt Discount and Financing Costs

-

(99)

Interest Expense

(96)

(194)

Loss Before Taxes from Continuing Operations

(214)

(1,324)

Tax Benefit

-

(64)

Net Loss from Continuing Operations

(214)

(1,260)

Loss from Discontinued Operations

(49)

(59)

Net Loss

$ ( 263)

$ ( 1,319)

Loss Per Share

Loss from Continuing Operations

($0.01)

($0.03)

Loss from Discontinued Operations

($0.00)

($0.00)

Net loss per share

($0.01)

($0.03)

Weighted Average Shares Outstanding

52,351,650

44,163,269

 

  

 

 

 

PROPHOTONIX LIMITED

CONSOLIDATED BALANCE SHEETS

In thousands except share and per share data

Unaudited

 

March 31,2011

 

December 31,2010

 

Assets

Current assets:

Cash and cash equivalents

$ 1,029

$ 1,811

Accounts receivable less allowances of $34 at March 31, 2011 and $47 at December 31, 2010

2,240

2,023

Inventories

2,086

1,892

Prepaid expenses and other current assets

234

229

 

 

Total current assets

5,589

5,955

Net property, plant and equipment

901

906

Goodwill

498

468

Acquired intangible assets, net

551

610

Other long-term assets

61

66

 

 

Total assets

$ 7,600

$ 8,005

 

 

Liabilities and Stockholders' Deficit

Current liabilities:

Revolving credit facility

$ 802

$ 641

Current portion of long-term debt

600

600

Current portion of capital lease obligations

17

24

Accounts payable

1,831

2,003

Accrued expenses

1,256

1,368

 

 

Total current liabilities

4,506

4,636

Long-term debt, net of current portion

3,424

3,407

Other long-term liabilities

178

150

 

 

Total liabilities

8,108

8,193

Stockholders' deficit:

Common stock, par value $0.001; shares authorized 100,000,000; 52,510,174 shares issued and outstanding at March 31, 2011 and December 31, 2010

53

53

Paid-in capital

105,741

105,678

Accumulated other comprehensive income

136

256

Accumulated deficit

(106,438)

(106,175)

 

 

Total stockholders' deficit

(508)

(188)

 

 

Total liabilities and stockholders' deficit

$ 7,600

$ 8,005

 

 

 

 

 

PROPHOTONIX LIMITED

CONSOLIDATED STATEMENTS OF CASH FLOWS

Unaudited

($ In thousands)

Three Months EndedMarch 31,

 

2011

 

2010

 

Operations

Net loss

$ (263)

$ (1,319)

Loss from discontinued operations, net of tax

(49)

(59)

 

 

Loss from continuing operations

(214)

(1,260)

Adjustments to reconcile net loss to net cash used in operating activities:

Stock based compensation

63

120

Depreciation and amortization

159

222

Amortization of debt discount and financing costs

-

99

Provision for inventories

9

7

Provision for bad debts

-

4

Deferred income taxes

-

(64)

Other change in assets and liabilities:

Accounts receivable

(113)

(640)

Inventories

(112)

(48)

Prepaid expenses and other current assets

3

50

Accounts payable

(258)

322

Accrued expenses

(157)

(101)

 

 

Net cash used in operating activities

(592)

(1,289)

Net cash used in discontinued operations

(49)

(59)

 

 

Net cash used in operating activities

(641)

(1,348)

Financing

Borrowing of revolving credit facility

137

304

Principal repayment of long-term debt

(157)

(903)

 

 

Net cash used in financing activities

(20)

(599)

Investing

Payment of financing obligation

-

(36)

Purchase of plant and equipment

(32)

(15)

 

 

Net cash used in investing activities

(32)

(51)

Effect of exchange rate on cash

(89)

355

 

 

Net change in cash and equivalents

(782)

(1,643)

Cash and equivalents, beginning of period

1,811

4,478

 

 

Cash and equivalents, end of period

$ 1,029

$ 2,835

 

 

Supplemental disclosure of cash flow information:

Cash paid for interest

$ 96

$ 190

Cash paid for taxes

$ 15

$ -

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
QRFUGUWAAUPGGQW
Date   Source Headline
16th Dec 20217:00 amRNSSale of ProPhotonix and cancelation of AIM Listing
17th Nov 20217:00 amRNSNotice of GM
11th Nov 202111:05 amRNSSecond Price Monitoring Extn
11th Nov 202111:00 amRNSPrice Monitoring Extension
11th Nov 20217:00 amRNSProPhotonix Announces Merger Agreement
2nd Nov 20217:00 amRNSProPhotonix Extends COBRA HyperSpec range
14th Sep 20217:00 amRNSProPhotonix announces the new UV COBRA Cure FX4
8th Sep 20217:00 amRNS2021 Half-year Report
9th Jun 20217:00 amRNSPosting of Annual Report and Accounts
2nd Jun 20217:00 amRNSNew Wavelengths added to UVC LED System
25th Mar 20217:00 amRNSResults for the year ended December 31, 2020
26th Jan 20217:00 amRNSNew Hyperspectral COBRA MultiSpec LED Line Light
16th Nov 20202:05 pmRNSSecond Price Monitoring Extn
16th Nov 20202:00 pmRNSPrice Monitoring Extension
12th Nov 20207:00 amRNSAdmission of Shares
10th Nov 20207:00 amRNSProPhotonix introduces 265nm UVC LED Lamp
9th Nov 20204:45 pmRNSResult of AGM and Director / PDMR Shareholdings
9th Oct 20207:00 amRNSPOSTING OF NOTICE OF ANNUAL GENERAL MEETING
8th Oct 20207:00 amRNSNew RGB-IR & RGB-White COBRA MultiSpec Line Lights
7th Oct 20203:07 pmRNSHolding(s) in Company
10th Sep 20207:00 amRNSINTERIM RESULTS FOR HALF YEAR ENDED JUNE 30, 2020
3rd Sep 20204:40 pmRNSSecond Price Monitoring Extn
3rd Sep 20204:35 pmRNSPrice Monitoring Extension
3rd Sep 20202:05 pmRNSSecond Price Monitoring Extn
3rd Sep 20202:00 pmRNSPrice Monitoring Extension
2nd Sep 20207:00 amRNSPROdigii Digital Lasers Range - 5 New Wavelengths
27th Aug 20207:00 amRNSRESULTS FOR THE YEAR ENDED DECEMBER 31, 2019
25th Aug 20201:47 pmRNSNOTICE OF EXTENSION OF RIGHTS PLAN
24th Jul 20207:00 amRNSHolding(s) in Company
16th Jul 20207:00 amRNSChange of Adviser and Director Disclosures
29th Jun 20207:00 amRNSCustom LED Backlight wins VSD Innovators Award
23rd Jun 20207:00 amRNSAccounts Reporting Extension & Trading Update
30th Apr 20207:00 amRNSDirectorate Change
9th Apr 20207:00 amRNSCOVID – 19 and Trading Update
19th Mar 20207:00 amRNS3 Year Framework Product Supply & IP Agreement
16th Mar 20207:00 amRNSProPhotonix - UV LED Water Disinfection
16th Jan 20207:00 amRNSTrading Update 2019
26th Nov 20197:00 amRNSHolding(s) in Company
10th Oct 20197:00 amRNS5-Year Master Purchase Agreement - Fortune 50 CGLM
12th Sep 20197:00 amRNSProPhotonix to Exhibit UV Lamps at Labelexpo 2019
6th Sep 20197:00 amRNSProPhotonix issues Half-year Report
3rd Sep 20197:00 amRNSNew High-Powered Red Laser Diode from Ushio
31st May 201911:59 amRNSProPhotonix Notification of Major Holdings
31st May 201911:58 amRNSProPhotonix Notification of Major Holdings
24th May 20197:00 amRNSPPIX Issues Director/PDMR Shareholding Notice
23rd May 20197:00 amRNSPPIX Issues Director/PDMR Shareholding Notice
17th May 20197:00 amRNSProPhotonix Announces Trading Update
16th May 20195:58 pmRNSPPIX Announces AGM Results and PDMR Shareholdings
16th May 20197:00 amRNSPPIX Offers New COBRA Cure Mini UV Curing System
9th Apr 20197:00 amRNSProPhotonix Honored by Vision Systems Design 2019

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.